New Gold Completes Redemption Of Its Remaining Outstanding 6.375% Senior Notes
PR Newswire TORONTO , May 16, 2022 /PRNewswire/ – New Gold Inc. (“New Gold” or the “Company”) (TSX: NGD) (NYSE American: NGD) announces completion of the previously announced redemption of its outstanding $100 million aggregate ... [Read]
Inmagene Receives FDA IND Clearance for a Third Generation BTK Inhibitor Targeting Immunological Diseases
PR Newswire SAN DIEGO and SHANGHAI , May 15, 2022 /PRNewswire/ — Inmagene Biopharmaceuticals (“Inmagene”) announces that today the U.S. Food and Drug Administration (FDA) cleared its investigational new drug (IND) application for the drug ... [Read]
Calliditas Therapeutics Launches an Online Patient Platform
This launch coincides with the inaugural IgAN Awareness Day STOCKHOLM, Sweden, May 14, 2022 (GLOBE NEWSWIRE) — Calliditas Therapeutics AB (Nasdaq: CALT, Nasdaq Stockholm: CALTX) (“Calliditas”) today announced the launch of IgAN Connect, a new ... [Read]
Stock Market Today: Dow Jones, S&P 500 Pushes Higher; Affirm Stock Surges On Solid Earnings & Partnership With Shopify
Stock Market Today Mid-Morning Updates On Friday, the Dow Jones Industrial Average is up by 380 points despite concerns over persistent inflation and worries on whether the Federal Reserve can get inflation under control. Fed ... [Read]
Signal Gold (Formerly Anaconda Mining) Announces Results from Annual and Special Meeting of Shareholders
TORONTO, ON / ACCESSWIRE / May 12, 2022 / Signal Gold Inc., previously Anaconda Mining Inc., (“Signal Gold” or the “Company”) (TSX:ANX) (OTCQX:ANXGF) is pleased to announce that it has changed its name to Signal ... [Read]
Fortuna Reports Net Income of $27.0 million in the First Quarter of 2022
(All amounts expressed in US dollars, tabular amounts in millions, unless otherwise stated) VANCOUVER, British Columbia, May 11, 2022 (GLOBE NEWSWIRE) — Fortuna Silver Mines Inc. (NYSE: FSM) (TSX: FVI) (“Fortuna” or the “Company”) today ... [Read]
Aileron Therapeutics Announces Late-Breaking Oral Presentation of Non-Clinical Data Demonstrating ALRN-6924 Protected Human Hair Follicles and Their Stem Cells from Chemotherapy-Induced Damage at Upcoming Society for Investigative Dermatology 2022 Annual Meeting
Taxanes, such as paclitaxel and docetaxel, cause severe and often permanent chemotherapy-induced hair loss (alopecia) New non-clinical data demonstrate proof of principle that ALRN-6924 can temporarily arrest the cell cycle in human scalp hair follicles ... [Read]
4 Buy-Ranked Non-Energy Stocks That Reported Solid Results Last Week
The energy sector is doing amazingly well for a number of reasons that most of us are already quite familiar with. Since the energy boom is likely to stretch further into the foreseeable future (Zacks ... [Read]
Best Stocks To Invest In 2022? 4 Software Stocks For Your List
Do You Have These Software Stocks On Your Radar Now? Amid the volatility in the stock market over the past year, many investors may argue that software stocks are potentially a bargain at their current ... [Read]
TrueCar Named in the Top 100 Most Consumer-Centric Companies of 2022
PR Newswire SANTA MONICA, Calif. , May 6, 2022 /PRNewswire/ — TrueCar , Inc. (NASDAQ: TRUE), the easiest, most efficient and transparent online destination for buying and selling new and used vehicles, announced its inclusion ... [Read]